Our conclusion is based on three observations on the ability of FKHR-PAX3 to: (1) enable a sustainable high PAX3-FKHR expression in non-transformed cells, (2) block myogenic differentiation, and (3) promote proliferation under suboptimal growth conditions and induce early tumor formation in mice. This evidence concerns the gene PAX3 and neoplasm.